Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityNo recent work listed

Mengtao Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0613-1656; OpenAlex author ID A5101990627. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
19
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 2 papers · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: 1 paper

Papers 7

  1. Corrigendum: Natural Killer Cell-Derived Exosomal miR-3607-3p Inhibits Pancreatic Cancer Progression by Targeting IL-26. Last author DOI 10.3389/fimmu.2020.00277↗
  2. Restoration of miRNA-148a in pancreatic cancer reduces invasion and metastasis by inhibiting the Wnt/β-catenin signaling pathway via downregulating maternally … Co-author DOI 10.3892/etm.2018.7026↗
  3. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma. Last author DOI 10.1111/jgh.13676↗
  4. Erratum: Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells [Corri… Last author DOI 10.2147/ott.s140829↗
  5. Sedum sarmentosum Bunge extract induces apoptosis and inhibits proliferation in pancreatic cancer cells via the hedgehog signaling pathway. Co-author DOI 10.3892/or.2016.4679↗
  6. Mitochondrial tRNALeu(CUN) A12307G variant may not be associated pancreatic cancer. Co-author DOI 10.4238/gmr.15027906↗
  7. Effect of NK4 transduction in bone marrow-derived mesenchymal stem cells on biological characteristics of pancreatic cancer cells. Co-author DOI 10.3390/ijms15033729↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Keqing Shi · 2 shared papers, 2017–2020 · strength 0.19
  2. Shengjie Dai · 2 shared papers, 2017–2020 · strength 0.18
  3. Bicheng Chen · 2 shared papers, 2016–2017 · strength 0.14
  4. Yunpeng Sun · 2 shared papers, 2014–2019 · strength 0.14
  5. Yunfeng Shan · 2 shared papers, 2014–2019 · strength 0.14
  6. Qiyu Zhang · 2 shared papers, 2014–2019 · strength 0.14
  7. Hongwei Sun · 1 shared paper, 2020 · strength 0.11
  8. Qiandong Zhu · 1 shared paper, 2019 · strength 0.10
  9. Fuxiang Yu · 1 shared paper, 2019 · strength 0.10
  10. Jie Xu · 1 shared paper, 2017 · strength 0.08
  11. Tingting Ye · 1 shared paper, 2017 · strength 0.07
  12. Xince Huang · 1 shared paper, 2017 · strength 0.07
  13. Dinglai Yu · 1 shared paper, 2017 · strength 0.07
  14. Chaohao Huang · 1 shared paper, 2017 · strength 0.07
  15. Y. Li · 1 shared paper, 2016 · strength 0.07
  16. Hongwei Sun · 1 shared paper, 2016 · strength 0.07
  17. Lan Zhou · 1 shared paper, 2016 · strength 0.07
  18. Yongheng Bai · 1 shared paper, 2016 · strength 0.07
  19. Huanhuan Wu · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.